Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;11(1):26-31.

Short Term Effects of Tiotropium on COPD Patients Treated with Long Acting Bronchodilators

Antonello Nicolini  1
Affiliations

Short Term Effects of Tiotropium on COPD Patients Treated with Long Acting Bronchodilators

Antonello Nicolini. Tanaffos. 2012.

Abstract

Background: The results of bronchodilator therapy in chronic obstructive pulmonary disease (COPD) are not satisfactory and because of this, many drugs are administered for treatment of disease. We examined the short-term additive bronchodilator effects of tiotropium in patients with stable COPD already treated with salmeterol twice daily.

Materials and methods: In a double-blind, double-dummy randomized study we evaluated the acute bronchodilator efficacy of a single 18 µg dose of tiotropium in patients with COPD under chronic treatment with a long acting beta-adrenergic (salmeterol 50µg twice a day). Measurements of forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1) and six-minute walking test (6 MWT) as indicator of daily activities were made before and after giving the drug. A total of 129 outpatients with stable COPD (Gold level 2 -3- 4) were enrolled and 92 completed the study.

Results: Tiotropium elicited a significantly greater bronchodilation than the placebo. The action of the drug was elicited as increase in FEV1 (p ≤ 0.001) and FVC (p ≤ 0.001); 6-MWT increased 35 meters in patients treated with tiotropium compared to 2.5 meters in those receiving placebo (p ≤ 0.001).

Conclusion: Addition of tiotropium to chronic administration of a beta-adrenergic drug such as salmeterol induced an increase in pulmonary function parameters and in exercise capacity suggesting that association of the two drugs can be more efficient for treatment of disease and improvement of daily living activities than beta-adrenergics alone.

Keywords: Chronic obstructive pulmonary disease; Pulmonary function; Six-minute walk test; Tiotropium.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Patients ‘ flow chart
Figure 2
Figure 2
Median changes in FEV1 (ml) before the administration of tiotropium (group 1) and placebo (group 2) and after the administration of tiotropium and placebo (p< 0.001)
Figure 3
Figure 3
Median changes in FEV1 (ml) before the administration of tiotropium (group 1) and placebo (group 2) and after the administration of tiotropium and placebo (p < 0.001).
Figure 4
Figure 4
Median changes in 6 MWT (meters) before the administration of tiotropium (group 1) and placebo (group 2) and after the administration of tiotropium and placebo (p < 0.001).
See this image and copyright information in PMC

References

    1. Hodder R, Kesten S, Menjoge S, Viel K. Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids. Int J Chron Obstruct Pulmon Dis. 2007;2(2):157–67. - PMC - PubMed
    1. Anzueto A. Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions. Am J Med. 2006;119(10 Suppl 1):46–53. - PubMed
    1. Barnes PJ. New development in anticholinergic drugs. Eur Respir Rev. 1996;6:290–4.
    1. Celli BR. The importance of spirometry in COPD and asthma: effect on approach to management. Chest. 2000;117(2 Suppl):15S–9S. - PubMed
    1. O'Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164(5):770–7. - PubMed

LinkOut - more resources